A biomarker panel comprising apolipoprotein E (APOE), pyruvate kinase L/R (PKLR), and galactokinase 1 (GALK1) was developed to differentiate iCCA from HCC [75]. This evidence concerns the gene GALK1 and hepatocellular carcinoma.